Medication safety

2384's picture

Health Care Practitioners' Perceptions of Transdermal Therapeutic Systems in Palestinian Territories

Journal Title, Volume, Page: 
Asian Journal of Pharmaceutics,; 3 (4) 304-308.
Year of Publication: 
2009
Authors: 
Zaid Abdel Naser
Department of Chemistry and Pharmaceutical Technology, College of Pharmacy, An-Najah National University, Nablus, Palestine,
Current Affiliation: 
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

To evaluate the scientific knowledge and attitudes of health professionals in Palestine regarding the advantages of transdermal therapeutic systems (TTSs) over conventional therapy . Data were gathered from a questionnaire that was handed out to community pharmacists and physicians. Pharmaceutical industry decision makers were enrolled in this study. Data were analyzed using the SPSS statistical software program version 10 . 79.5% of pharmacists and 74% of physicians thought that TTSs eliminate variables due to gut absorption. 78.8% of pharmacists and 65.6% of physicians were in agreement regarding the capacity of TTSs to avoid first-pass metabolism. In this study, 83.3% of the physicians and 81.3% pharmacists still agree that TTSs may provide controlled release. 55.8% of pharmacists and only 26% of physicians believed that TTSs eliminate drug-plasma fluctuation. 56.8% of pharmacists and 63.5% of physicians agreed that TTSs can use drugs with low therapeutic indices. 81.3% of pharmacists and 85.4% of physicians believed that TTSs are not invasive and can be removed easily to stop drug administration. 81.3% of physicians and 89.1% of pharmacists thought that TTSs may irritate or sensitize the skin. Eighty-four percent of pharmacists and 75% of physicians recognize that TTSs should contain drugs that must be stable and have correct physicochemical properties.The importance of TTSs is understood and appreciated by Palestinian health personnel. Pharmaceutical industries should pay more attention to the development and production of TTSs due to the valuable advantages of this therapeutic system.

Waleed Sweileh's picture

Contraindications to Metformin Therapy Among Patients with Type 2 Diabetes Mellitus

Journal Title, Volume, Page: 
Pharm World Sci., 29(6):573.
Year of Publication: 
2007
Authors: 
W. M. Sweileh
Clinical Pharmacology, College of Pharmacy, Clinical Pharmacy Graduate Program, An-Najah National University, P.O. Box 7,707, Nablus, Palestine
Current Affiliation: 
College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

OBJECTIVE:

The biguanide, metformin, is a commonly prescribed oral antihyperglycemic agent. However, there are several clinical conditions that are considered as contraindications to the use of metformin among patients with type 2 diabetes mellitus. The aim of this study was to investigate the presence and nature of contraindications to metformin therapy among patients with type 2 diabetes mellitus.

METHOD:

A retrospective study of the medical files of diabetic patients available at Alwosta clinic, north Palestine was carried out. Information about disease and medication profile of the patients was retrieved and analyzed using SPSS during the study period in 2004/2005. Focus was on metformin users who have contraindications to metfromin therapy.

MAIN OUTCOME MEASURE:

Presence and number of contraindications to metformin therapy.

RESULTS:

Two hundred and seventy-two type 2 diabetic patients were identified. One hundred and twenty four of those diabetic patients were metformin users. Approximately, 60% of patients in the metformin group had a least one contraindication. Congestive heart failure and renal impairment were the most quantitatively present contraindications.

CONCLUSION:

Contraindications to metformin therapy are common among type 2 diabetic patients and mostly disregarded. Patients have to be critically assessed before starting therapy and in case of metformin prescribing; dose should be adjusted based on the presence of risk factors for metformin adverse effects.

Syndicate content